Susan Elizabeth Arnold - 12 Jul 2021 Form 4/A - Amendment Insider Report for PhaseBio Pharmaceuticals Inc

Role: VP, Preclinical and Chem
Signature: /s/ John P. Sharp, Attorney-in-fact
Issuer symbol: N/A
Transactions as of: 12 Jul 2021
Net transactions value: +$7,863
Form type: 4/A - Amendment
Filing time: 03 Sep 2021, 16:43:36 UTC
Date Of Original Report: 14 Jul 2021
Previous filing: 24 May 2021
Next filing: 23 Nov 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PHASQ	Common Stock	Options Exercise	$7,863	+4,519	+19%	$1.74^*	27,760	12 Jul 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PHASQ	Employee Stock Option (right to buy)	Options Exercise	$0	-4,519	-100%	$0.000000^*	0	12 Jul 2021	Common Stock	4,519	$1.74	Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Amended to correct the transaction code for common stock acquired through stock options exercised in a transaction on July 12, 2021.
F2	Amended to add a transaction for the exercise of stock options on July 12, 2021.
F3	All shares underlying this option have vested.